ロード中...
Customised, Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC)
A series of phase II and randomised phase III trials in Asia and Europe have confirmed recently that advanced stage non-small-cell lung carcinoma patients with adenocarcinoma subtypes harbouring specific mutations when subjected to targeted therapy experience equivalent survival outcomes as those tr...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3706109/ https://ncbi.nlm.nih.gov/pubmed/23862025 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|